Answer
Yes, intravenous belimumab (Benlysta) is indicated for adults with active lupus nephritis in combination with background immunosuppressive therapies.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 35Document updated
Sources checked